Correlation Between Eliem Therapeutics and Theriva Biologics
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Theriva Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Theriva Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Theriva Biologics, you can compare the effects of market volatilities on Eliem Therapeutics and Theriva Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Theriva Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Theriva Biologics.
Diversification Opportunities for Eliem Therapeutics and Theriva Biologics
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Eliem and Theriva is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Theriva Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Theriva Biologics and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Theriva Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Theriva Biologics has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Theriva Biologics go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Theriva Biologics
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 0.93 times more return on investment than Theriva Biologics. However, Eliem Therapeutics is 1.07 times less risky than Theriva Biologics. It trades about 0.04 of its potential returns per unit of risk. Theriva Biologics is currently generating about -0.03 per unit of risk. If you would invest 253.00 in Eliem Therapeutics on August 30, 2024 and sell it today you would earn a total of 51.00 from holding Eliem Therapeutics or generate 20.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eliem Therapeutics vs. Theriva Biologics
Performance |
| Timeline |
| Eliem Therapeutics |
| Theriva Biologics |
Eliem Therapeutics and Theriva Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Theriva Biologics
The main advantage of trading using opposite Eliem Therapeutics and Theriva Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Theriva Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theriva Biologics will offset losses from the drop in Theriva Biologics' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Theriva Biologics vs. Lumos Pharma | Theriva Biologics vs. Avalo Therapeutics | Theriva Biologics vs. Virpax Pharmaceuticals | Theriva Biologics vs. Revelation Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |